Physician profile
Henry Su
NPI 1174594253
$2,630.23
in general payments reported to CMS, 2019-2025
21 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $203 · 2021: $699 · 2022: $746 · 2023: $379 · 2024: $233 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.00 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,017.50 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Sumitomo Pharma America, INC. | $181.26 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $172.07 | 2021-2022 | |
| Astellas Pharma US INC | $169.51 | 2022-2025 | Veozah |
| Myovant Sciences INC. | $136.12 | 2022 | |
| Mylan Pharmaceuticals INC. | $125.75 | 2019-2022 | |
| Evofem Biosciences, INC. | $119.38 | 2021-2022 | |
| Hologic Sales and Service, LLC | $100.10 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $92.92 | 2020-2023 | Gardasil 9 |
| Novo Nordisk INC | $90.43 | 2023-2024 | Wegovy |
| Exeltis, USA INC. | $88.24 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $82.45 | 2022-2023 | |
| Organon LLC | $58.55 | 2022-2024 | |
| Pfizer INC. | $49.97 | 2022 | |
| Sage Therapeutics, LLC | $32.36 | 2024-2025 | Zurzuvae |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $27.21 | 2020 | |
| Xeris Pharmaceuticals, INC. | $22.22 | 2023 | Gvoke Hypopen |
| Baxter Healthcare | $16.78 | 2024 | Perclot |
| Covidien LP | $16.74 | 2020 | |
| Amag Pharmaceuticals, INC. | $15.90 | 2021 | |
| Supernus Pharmaceuticals, INC. | $14.77 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.